Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 3/20 | 0.38 |
| ▸ | SMOX | Q9NWM0 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31532956 | 1.00 | PAOX (0.39) | PAOXGAAKMT2AKDM1ASMOX | |
| SCHEMBL20262062 | 1.00 | PAOX (0.39) | PAOXGAAKMT2AKDM1ASMOX | |
| SCHEMBL3079468 | 1.00 | PAOX (0.39) | PAOXGAAKMT2AKDM1ASMOX | |
| SCHEMBL2363695 | 1.00 | PAOX (0.39) | PAOXGAAKMT2AKDM1ASMOX | |
| SCHEMBL7040220 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL28130617 | 0.95 | SMOX (0.43) | PAOXGAAKMT2AKDM1ASMOX | |
| SCHEMBL1083160 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL27952728 | 0.88 | — | — | |
| SCHEMBL17291817 | 0.87 | PAOX (0.48) | PAOXGAAKMT2AKDM1ASMOX | |
| SCHEMBL5611725 | 0.87 | PAOX (0.48) | PAOXGAAKMT2AKDM1ASMOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718564-B2 | Partially decomposed catalyst and hydrocarbon oxidation processes using the same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-05-18 | — | — | US | claimed |
| US-7605107-B2 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-10-20 | — | — | US | claimed |
| US-7538066-B2 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-05-26 | — | — | US | claimed |
| US-20070082811-A1 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-04-12 | — | — | US | claimed |
| US-20070072765-A1 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-03-29 | — | — | US | claimed |
| EP-2531480-B1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-01-16 | — | — | EP | disclosed |
| US-9035107-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-19 | — | — | US | disclosed |
| US-9024078-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-8969639-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-03-03 | — | — | US | disclosed |
| US-8884075-B2 | Process for producing phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-20140148620-A1 | Process for Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-05-29 | — | — | US | disclosed |
| US-20120323046-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-12-20 | — | — | US | disclosed |
| US-20120302798-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-11-29 | — | — | US | disclosed |
| US-20120271077-A1 | Dehydrogenation Process | EXXONMOBILE CHEMICAL PATENTS INC. (US) | 2012-10-25 | — | — | US | disclosed |
| WO-2012050665-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2011096992-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096997-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096994-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| US-7718564-B2 | Partially decomposed catalyst and hydrocarbon oxidation processes using the same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-05-18 | — | — | US | disclosed |
| US-20060293544-A1 | Partially decomposed catalyst and hydrocarbon oxidation processes using the same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148620-A1 | Process for Producing Phenol | HPD, CYP2J2, CYP2E1 | PAOX 1051/4885GAA 1989/4885KMT2A 3345/4885 |
| US-20120271077-A1 | Dehydrogenation Process | ADH5, ADH1A, ADH1C | PAOX 271/4885GAA 4564/4885KMT2A 2800/4885 |
| US-20120302798-A1 | Dehydrogenation Process | NDUFV1, NDUFV2, MAFG | PAOX 3231/4885GAA 3049/4885KMT2A 582/4885 |
| US-20120323046-A1 | Dehydrogenation Process | ADH1A, ADH5, ADH1C | PAOX 532/4885GAA 3913/4885KMT2A 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.